Recent Finacing
Recent Raise
Arrien Pharmaceuticals develops small-molecule therapeutics via a proprietary platform targeting cell signaling pathways, advancing preclinical programs in Parkinson’s, Alzheimer’s, cancer, rheumatoid arthritis, type 2 diabetes, and obesity.
Focus Areas
Funding round